186 related articles for article (PubMed ID: 23741347)
1. Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure.
Liu Y; Bai R; Wang L; Zhang C; Zhao R; Wan D; Chen X; Caceres G; Barr D; Barajas-Martinez H; Antzelevitch C; Hu D
PLoS One; 2013; 8(5):e64603. PubMed ID: 23741347
[TBL] [Abstract][Full Text] [Related]
2. Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease.
Hu D; Hu D; Liu L; Barr D; Liu Y; Balderrabano-Saucedo N; Wang B; Zhu F; Xue Y; Wu S; Song B; McManus H; Murphy K; Loes K; Adler A; Monserrat L; Antzelevitch C; Gollob MH; Elliott PM; Barajas-Martinez H
EBioMedicine; 2020 Apr; 54():102723. PubMed ID: 32259713
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
[TBL] [Abstract][Full Text] [Related]
4. A novel, de novo mutation in the
Xu Y; Gray A; Hardie DG; Uzun A; Shaw S; Padbury J; Phornphutkul C; Tseng YT
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H283-H292. PubMed ID: 28550180
[No Abstract] [Full Text] [Related]
5. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
6. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
[TBL] [Abstract][Full Text] [Related]
7. Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development.
Tan HL; van der Wal AC; Campian ME; Kruyswijk HH; ten Hove Jansen B; van Doorn DJ; Oskam HJ; Becker AE; Wilde AA
Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):276-81. PubMed ID: 19808419
[TBL] [Abstract][Full Text] [Related]
8. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N
Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
Zhang BL; Xu RL; Zhang J; Zhao XX; Wu H; Ma LP; Hu JQ; Zhang JL; Ye Z; Zheng X; Qin YW
J Cardiol; 2013 Oct; 62(4):241-8. PubMed ID: 23778007
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis.
Lopez-Sainz A; Dominguez F; Lopes LR; Ochoa JP; Barriales-Villa R; Climent V; Linschoten M; Tiron C; Chiriatti C; Marques N; Rasmussen TB; Espinosa MÁ; Beinart R; Quarta G; Cesar S; Field E; Garcia-Pinilla JM; Bilinska Z; Muir AR; Roberts AM; Santas E; Zorio E; Peña-Peña ML; Navarro M; Fernandez A; Palomino-Doza J; Azevedo O; Lorenzini M; García-Álvarez MI; Bento D; Jensen MK; Méndez I; Pezzoli L; Sarquella-Brugada G; Campuzano O; Gonzalez-Lopez E; Mogensen J; Kaski JP; Arad M; Brugada R; Asselbergs FW; Monserrat L; Olivotto I; Elliott PM; Garcia-Pavia P;
J Am Coll Cardiol; 2020 Jul; 76(2):186-197. PubMed ID: 32646569
[TBL] [Abstract][Full Text] [Related]
11. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.
Hinson JT; Chopra A; Lowe A; Sheng CC; Gupta RM; Kuppusamy R; O'Sullivan J; Rowe G; Wakimoto H; Gorham J; Burke MA; Zhang K; Musunuru K; Gerszten RE; Wu SM; Chen CS; Seidman JG; Seidman CE
Cell Rep; 2016 Dec; 17(12):3292-3304. PubMed ID: 28009297
[TBL] [Abstract][Full Text] [Related]
12. Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy.
Ahmad F; Arad M; Musi N; He H; Wolf C; Branco D; Perez-Atayde AR; Stapleton D; Bali D; Xing Y; Tian R; Goodyear LJ; Berul CI; Ingwall JS; Seidman CE; Seidman JG
Circulation; 2005 Nov; 112(20):3140-8. PubMed ID: 16275868
[TBL] [Abstract][Full Text] [Related]
13. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
[TBL] [Abstract][Full Text] [Related]
14. Cardiac MR manifestations in two cases of PRKAG2 mutations in a Chinese family.
Wang J; Li X; Xu Y
Int J Cardiovasc Imaging; 2020 Aug; 36(8):1527-1531. PubMed ID: 32314121
[TBL] [Abstract][Full Text] [Related]
15. Human γ2-AMPK Mutations.
Yavari A; Sarma D; Sternick EB
Methods Mol Biol; 2018; 1732():581-619. PubMed ID: 29480501
[TBL] [Abstract][Full Text] [Related]
16. Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.
Kim M; Hunter RW; Garcia-Menendez L; Gong G; Yang YY; Kolwicz SC; Xu J; Sakamoto K; Wang W; Tian R
Circ Res; 2014 Mar; 114(6):966-75. PubMed ID: 24503893
[TBL] [Abstract][Full Text] [Related]
17. A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation.
Yang KQ; Lu CX; Zhang Y; Yang YK; Li JC; Lan T; Meng X; Fan P; Tian T; Wang LP; Liu YX; Zhang X; Zhou XL
Sci Rep; 2017 May; 7(1):2407. PubMed ID: 28546535
[TBL] [Abstract][Full Text] [Related]
18. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW
Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
[TBL] [Abstract][Full Text] [Related]
20. Novel PRKAG2 Variant Manifesting with a Cardiac Arrest in a Child.
Spentzou G; McGowan R; Hares D; McLeod K
Pediatr Cardiol; 2020 Apr; 41(4):843-845. PubMed ID: 31720784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
